Human Embryonic Stem Cells Do Not Change Their X Inactivation Status during Differentiation.

PubWeight™: 0.82‹?›

🔗 View Article (PMID 27989715)

Published in Cell Rep on December 15, 2016

Authors

Sanjeet Patel1, Giancarlo Bonora1, Anna Sahakyan1, Rachel Kim1, Constantinos Chronis1, Justin Langerman1, Sorel Fitz-Gibbon2, Liudmilla Rubbi2, Rhys J P Skelton3, Reza Ardehali3, Matteo Pellegrini2, William E Lowry2, Amander T Clark2, Kathrin Plath4

Author Affiliations

1: Department of Biological Chemistry, Molecular Biology Institute, Jonsson Comprehensive Cancer Center, Bioinformatics Program, Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA.
2: Department of Molecular, Cell and Developmental Biology, University of California, Los Angeles, Los Angeles, CA 90095, USA.
3: Division of Cardiology, Department of Internal Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA.
4: Department of Biological Chemistry, Molecular Biology Institute, Jonsson Comprehensive Cancer Center, Bioinformatics Program, Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA. Electronic address: kplath@mednet.ucla.edu.

Articles citing this

X-chromosome dosage as a modulator of pluripotency, signalling and differentiation? Philos Trans R Soc Lond B Biol Sci (2017) 0.82

Human X chromosome inactivation and reactivation: implications for cell reprogramming and disease. Philos Trans R Soc Lond B Biol Sci (2017) 0.81

Regulation of X-chromosome dosage compensation in human: mechanisms and model systems. Philos Trans R Soc Lond B Biol Sci (2017) 0.80

Memories of an X-chromosome. Stem Cell Investig (2017) 0.75

Epigenetic resetting of human pluripotency. Development (2017) 0.75

Articles cited by this

Embryonic stem cell lines derived from human blastocysts. Science (1998) 65.53

Role of histone H3 lysine 27 methylation in X inactivation. Science (2003) 9.85

Reduced representation bisulfite sequencing for comparative high-resolution DNA methylation analysis. Nucleic Acids Res (2005) 8.69

Reference Maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell (2011) 8.21

Derivation of pre-X inactivation human embryonic stem cells under physiological oxygen concentrations. Cell (2010) 4.32

X-chromosome inactivation and epigenetic fluidity in human embryonic stem cells. Proc Natl Acad Sci U S A (2008) 3.25

Recurrent variations in DNA methylation in human pluripotent stem cells and their differentiated derivatives. Cell Stem Cell (2012) 2.94

Eutherian mammals use diverse strategies to initiate X-chromosome inactivation during development. Nature (2011) 2.75

Female human iPSCs retain an inactive X chromosome. Cell Stem Cell (2010) 2.59

DNA methylation dynamics of the human preimplantation embryo. Nature (2014) 2.55

X-inactivation in female human embryonic stem cells is in a nonrandom pattern and prone to epigenetic alterations. Proc Natl Acad Sci U S A (2008) 2.53

Regulation of X-chromosome inactivation by the X-inactivation centre. Nat Rev Genet (2011) 2.50

Erosion of dosage compensation impacts human iPSC disease modeling. Cell Stem Cell (2012) 2.42

Global hypomethylation of the genome in XX embryonic stem cells. Nat Genet (2005) 2.35

Histone deacetylase inhibition elicits an evolutionarily conserved self-renewal program in embryonic stem cells. Cell Stem Cell (2009) 2.09

X-inactivation status varies in human embryonic stem cell lines. Stem Cells (2005) 1.84

Translating dosage compensation to trisomy 21. Nature (2013) 1.75

DNA methylation profiles of human active and inactive X chromosomes. Genome Res (2011) 1.68

Dosage compensation of the sex chromosomes. Annu Rev Genet (2012) 1.59

X-inactivation reveals epigenetic anomalies in most hESC but identifies sublines that initiate as expected. J Cell Physiol (2008) 1.59

Unexpected X chromosome skewing during culture and reprogramming of human somatic cells can be alleviated by exogenous telomerase. Cell Stem Cell (2011) 1.58

Histone variant macroH2A confers resistance to nuclear reprogramming. EMBO J (2011) 1.57

Human Naive Pluripotent Stem Cells Model X Chromosome Dampening and X Inactivation. Cell Stem Cell (2016) 1.49

Tracking the progression of the human inner cell mass during embryonic stem cell derivation. Nat Biotechnol (2012) 1.45

Derivation conditions impact X-inactivation status in female human induced pluripotent stem cells. Cell Stem Cell (2012) 1.35

Molecular signatures of human induced pluripotent stem cells highlight sex differences and cancer genes. Cell Stem Cell (2012) 1.23

Role and control of X chromosome dosage in mammalian development. Curr Opin Genet Dev (2013) 1.12

The pluripotent state in mouse and human. Development (2015) 1.05

Erosion of X Chromosome Inactivation in Human Pluripotent Cells Initiates with XACT Coating and Depends on a Specific Heterochromatin Landscape. Cell Stem Cell (2015) 1.04

Derivation of consensus inactivation status for X-linked genes from genome-wide studies. Biol Sex Differ (2015) 1.00

X Chromosome of female cells shows dynamic changes in status during human somatic cell reprogramming. Stem Cell Reports (2014) 0.94

Stable X chromosome reactivation in female human induced pluripotent stem cells. Stem Cell Reports (2015) 0.89

Female mice lacking Xist RNA show partial dosage compensation and survive to term. Genes Dev (2016) 0.78

The dynamic changes of X chromosome inactivation during early culture of human embryonic stem cells. Stem Cell Res (2016) 0.77